‘Liquid DNA Biopsy’ Helps to Spot Ovarian Cancer Patients at Risk of Relapse

‘Liquid DNA Biopsy’ Helps to Spot Ovarian Cancer Patients at Risk of Relapse
Ovarian cancer relapses may be effectively monitored and, possibly, detected early by analyzing patients’ DNA in blood samples, Mayo Clinic researchers report in the study, “Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers,” published in the journal Science Reports. When tumor cells are dying, they release DNA into the blood stream that differs from the DNA derived from non-cancerous tissue. This DNA “signature” can be

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , .

Chris Comish serves as the Publisher of the website, and is responsible for directing the editorial focus as well as putting the finishing touches on many featured articles.

Leave a Comment

Your email address will not be published. Required fields are marked *